2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide

C92H82N32O4S4 — CID 157449001

IUPAC2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide
SMILESCC(=O)Nc1ccc(Oc2nc(Nc3nncs3)c3ccccc3n2)cc1.CCN(CCc1ccccc1)c1nc(Nc2cnco2)c2ccccc2n1.CN1CCN(c2cc(Nc3cncs3)nc(N(C)c3ccc4ncsc4c3)n2)CC1.Cc1ncsc1Nc1nc(-c2ccccc2)nc2cc[nH]c12.c1cc2c(Nc3nnco3)nc(Cc3ccc4[nH]ncc4c3)nc2cn1
InChIInChI=1S/C21H21N5O.C20H22N8S2.C18H14N6O2S.C17H12N8O.C16H13N5S/c1-2-26(13-12-16-8-4-3-5-9-16)21-23-18-11-7-6-10-17(18)20(25-21)24-19-14-22-15-27-19;1-26-5-7-28(8-6-26)18-10-17(23-19-11-21-12-30-19)24-20(25-18)27(2)14-3-4-15-16(9-14)29-13-22-15;1-11(25)20-12-6-8-13(9-7-12)26-17-21-15-5-3-2-4-14(15)16(22-17)23-18-24-19-10-27-18;1-2-13-11(7-19-24-13)5-10(1)6-15-21-14-8-18-4-3-12(14)16(22-15)23-17-25-20-9-26-17;1-10-16(22-9-18-10)21-15-13-12(7-8-17-13)19-14(20-15)11-5-3-2-4-6-11/h3-11,14-15H,2,12-13H2,1H3,(H,23,24,25);3-4,9-13H,5-8H2,1-2H3,(H,23,24,25);2-10H,1H3,(H,20,25)(H,21,22,23,24);1-5,7-9H,6H2,(H,19,24)(H,21,22,23,25);2-9,17H,1H3,(H,19,20,21)
InChIKeyBSOMQKWAWSAIFC-UHFFFAOYSA-N
MW1828.16 g/mol
LogP18.96
Rot. Bonds24

About 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide

2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide (PubChem CID 157449001) has the molecular formula C92H82N32O4S4 and a molecular weight of 1828.16 g/mol. Its IUPAC name is 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide.

Molecular Properties

Compound Name2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide
PubChem CID157449001
Molecular FormulaC92H82N32O4S4
Molecular Weight1828.16 g/mol
Exact Mass1826.61
IUPAC Name2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide
SMILESCC(=O)Nc1ccc(Oc2nc(Nc3nncs3)c3ccccc3n2)cc1.CCN(CCc1ccccc1)c1nc(Nc2cnco2)c2ccccc2n1.CN1CCN(c2cc(Nc3cncs3)nc(N(C)c3ccc4ncsc4c3)n2)CC1.Cc1ncsc1Nc1nc(-c2ccccc2)nc2cc[nH]c12.c1cc2c(Nc3nnco3)nc(Cc3ccc4[nH]ncc4c3)nc2cn1
InChIInChI=1S/C21H21N5O.C20H22N8S2.C18H14N6O2S.C17H12N8O.C16H13N5S/c1-2-26(13-12-16-8-4-3-5-9-16)21-23-18-11-7-6-10-17(18)20(25-21)24-19-14-22-15-27-19;1-26-5-7-28(8-6-26)18-10-17(23-19-11-21-12-30-19)24-20(25-18)27(2)14-3-4-15-16(9-14)29-13-22-15;1-11(25)20-12-6-8-13(9-7-12)26-17-21-15-5-3-2-4-14(15)16(22-17)23-18-24-19-10-27-18;1-2-13-11(7-19-24-13)5-10(1)6-15-21-14-8-18-4-3-12(14)16(22-15)23-17-25-20-9-26-17;1-10-16(22-9-18-10)21-15-13-12(7-8-17-13)19-14(20-15)11-5-3-2-4-6-11/h3-11,14-15H,2,12-13H2,1H3,(H,23,24,25);3-4,9-13H,5-8H2,1-2H3,(H,23,24,25);2-10H,1H3,(H,20,25)(H,21,22,23,24);1-5,7-9H,6H2,(H,19,24)(H,21,22,23,25);2-9,17H,1H3,(H,19,20,21)
InChIKeyBSOMQKWAWSAIFC-UHFFFAOYSA-N
XLogP18.96
TPSA427.10 Ų
H-Bond Donors8
H-Bond Acceptors37
Rotatable Bonds24
Heavy Atoms132
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001828.16
LogP ≤ 518.96
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1037

Analyze 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide?
The IUPAC name of 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide (CID 157449001) is 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide.
What is the SMILES notation for 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide?
The canonical SMILES for 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide is CC(=O)Nc1ccc(Oc2nc(Nc3nncs3)c3ccccc3n2)cc1.CCN(CCc1ccccc1)c1nc(Nc2cnco2)c2ccccc2n1.CN1CCN(c2cc(Nc3cncs3)nc(N(C)c3ccc4ncsc4c3)n2)CC1.Cc1ncsc1Nc1nc(-c2ccccc2)nc2cc[nH]c12.c1cc2c(Nc3nnco3)nc(Cc3ccc4[nH]ncc4c3)nc2cn1.
What is the InChIKey of 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide?
The InChIKey is BSOMQKWAWSAIFC-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21N5O.C20H22N8S2.C18H14N6O2S.C17H12N8O.C16H13N5S/c1-2-26(13-12-16-8-4-3-5-9-16)21-23-18-11-7-6-10-17(18)20(25-21)24-19-14-22-15-27-19;1-26-5-7-28(8-6-26)18-10-17(23-19-11-21-12-30-19)24-20(25-18)27(2)14-3-4-15-16(9-14)29-13-22-15;1-11(25)20-12-6-8-13(9-7-12)26-17-21-15-5-3-2-4-14(15)16(22-17)23-18-24-19-10-27-18;1-2-13-11(7-19-24-13)5-10(1)6-15-21-14-8-18-4-3-12(14)16(22-15)23-17-25-20-9-26-17;1-10-16(22-9-18-10)21-15-13-12(7-8-17-13)19-14(20-15)11-5-3-2-4-6-11/h3-11,14-15H,2,12-13H2,1H3,(H,23,24,25);3-4,9-13H,5-8H2,1-2H3,(H,23,24,25);2-10H,1H3,(H,20,25)(H,21,22,23,24);1-5,7-9H,6H2,(H,19,24)(H,21,22,23,25);2-9,17H,1H3,(H,19,20,21).
What are the key properties of 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide?
2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide has a molecular weight of 1828.16 g/mol, XLogP of 18.96, 24 rotatable bonds, 8 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 2-N-(1,3-benzothiazol-6-yl)-2-N-methyl-6-(4-methylpiperazin-1-yl)-4-N-(1,3-thiazol-5-yl)pyrimidine-2,4-diamine;2-N-ethyl-4-N-(1,3-oxazol-5-yl)-2-N-(2-phenylethyl)quinazoline-2,4-diamine;N-[2-(1H-indazol-5-ylmethyl)pyrido[3,4-d]pyrimidin-4-yl]-1,3,4-oxadiazol-2-amine;4-methyl-N-(2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-1,3-thiazol-5-amine;N-[4-[4-(1,3,4-thiadiazol-2-ylamino)quinazolin-2-yl]oxyphenyl]acetamide is sourced from PubChem (CID 157449001), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).